Stroke Trial, Recruiting NCT07041775 Sponsor: Northwestern University Condition: Stroke
Back to Stroke

Stroke Trial, Recruiting

NCT07041775
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People between 18 and 85 years of age at the time of enrolment
  • People who have leg difficulties caused by a stroke on one side of the body, where the stroke happened at least 6 months before screening
  • People with moderate to severe walking difficulties, meaning the fastest walking speed possible is no more than 0.8 metres per second (roughly half of a typical walking speed)
  • People who are able to stand up without help from another person or a device
  • People who have a noticeable unevenness or imbalance in the way they walk, as observed by a clinician
  • People who show an abnormal muscle activation pattern between two specific leg muscles — the adductor magnus and rectus femoris — as measured during assessment (confirm with trial site)

Who may not be able to join:

  • People with thinking or attention difficulties that affect performance on a specific attention test (digit-span test), or who are unable to follow the instructions of a particular memory task used in the trial
  • People with vision problems (such as loss of half the visual field) that would prevent them from seeing a screen well enough to participate in the game-based activities
  • People with severe numbness, loss of sensation, or significant inattention affecting the stroke-affected leg, or a visual attention condition, at a level that would interfere with the game-based tasks
  • People who have participated in another study involving the affected leg, or any medication-based study, within 6 weeks of enrolment
  • People who are unable to understand or follow spoken instructions in English due to speech or language difficulties, or any other reason that would make training impossible
  • People with widespread or multiple areas of stroke-related brain injury
  • People experiencing significant leg pain or other pain that would prevent participation in 60-minute daily sessions
  • People who have received spasticity treatment — whether medication or Botox injections — in the affected leg within the past 3 months
  • People with severe bone thinning (osteoporosis) that has led to hip or other fractures
  • People with a history of multiple falls in the past year, those who use a walker for balance, or those who fall while standing during the first lab session
  • People with joint stiffness or tightening in the leg that limits its range of movement
  • People who are currently pregnant
  • For the brain stimulation (TMS) part of the study only: people with a history of epilepsy in adulthood requiring seizure medication; current or recent significant alcohol, benzodiazepine, or barbiturate misuse or recent withdrawal from these substances; recent cocaine or amphetamine use; skull fractures or gaps in the skull; a concussion within the last 6 months; unexplained recurring headaches; or certain implanted medical devices including a vagus nerve stimulator, cochlear implant, deep brain stimulator, brain or neck artery stents, or a heart pacemaker or defibrillator

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Marc Slutzky, MD, PhD, Northwestern University

Phone: 312-503-4653

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
4 June 2026
Est. completion
1 January 2030

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

10-m walk test

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov